Last updated: 3 months ago
Purple Biotech Ltd. Unveils Phase 2 Trial for NT219 in Head and Neck Cancer - February 2025 Update
Discover Purple Biotech's latest financial report highlighting the advancement of NT219 into Phase 2 trials for Head and Neck Cancer, crucial for investors and market positioning.